Literature DB >> 31192805

Is It Safe to Ask the Questions That Matter Most to Me? Observations From a Female Residency Applicant.

Alice N Weaver1, Lisa L Willett.   

Abstract

Tens of thousands of senior medical students interview for medical residency positions each year. As the applicant pool shifts to include more women, married individuals, and young parents, the criteria by which interviewees evaluate programs are also changing. Concerns including parental leave policies, lactation facilities, access to childcare, partner recruitment resources, and inclusivity in the work environment are important in selecting an ideal program. However, the National Resident Matching Program Match Communication Code of Conduct prohibits interviewers from addressing gender, marital status, and intent to bear children, so the burden of introducing such topics falls on the interviewees. These topics can be difficult to discuss with potential employers, especially when weighed against the pressure to obtain a competitive position through the Match.In this Invited Commentary, the authors draw on personal experience to examine the questions that residency programs need to answer, encouraging both applicants and programs to improve communication during the residency interview process.

Entities:  

Mesh:

Year:  2019        PMID: 31192805     DOI: 10.1097/ACM.0000000000002837

Source DB:  PubMed          Journal:  Acad Med        ISSN: 1040-2446            Impact factor:   6.893


  2 in total

1.  Identifying Barriers: Current Breastfeeding Policy in Orthopedic Surgery Residency.

Authors:  Malynda Wynn; Lindsey Caldwell; Heather Kowalski; Ericka Lawler
Journal:  Iowa Orthop J       Date:  2021

2.  Fellowship program directors and trainees across the United States find parental leave policies to be inconsistent, inaccessible, and inadequate.

Authors:  Daniel Sabido Jamorabo; Amrin Khander; Vasilios Koulouris; Jeremy Eli Feith; William Matthew Briggs; Benjamin Dwight Renelus
Journal:  PLoS One       Date:  2021-11-17       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.